Cisplatin ototoxycity and otoprotector to cilliated cells by ginkgo biloba extract: Anatomic and eletrophisiologic study;Ototoxicidade da cisplatina e otoproteção pelo extrato de ginkgo biloba às células ciliadas externas: Estudo anatômico e eletrofisiológico

Revista Brasileira de Otorrinolaringologia

Volumn 69, Issue 4, 2003, Pages 504-511

  Hyppolito, Miguel Angelo ^a   De Oliveira, José Antônio A ^a   Rossato, Maria ^a   Holanda, Francisco ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cisplatin; Ginkgo biloba; Otoprotective agents

Indexed keywords

CISPLATIN; COOPAZINE; GINKGO BILOBA EXTRACT; KETAMIN; KETAMINE; XYLAZINE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CILIATED EPITHELIUM; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EAR PROTECTION; ELECTROPHYSIOLOGY; GUINEA PIG; HAIR CELL; NONHUMAN; OTOTOXICITY; SCANNING ELECTRON MICROSCOPY;

EID: 12444306336     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992003000400011     Document Type: Article

References (62)

1. Laurell G, Engström B, Bagger-Sjöback D. Ototoxicity of Cisplatin. Int J Androl 1987;10:359-62.
2. Powis GD, Hacker MP. The Toxicity of Anticancer Drugs. New York: Pergamon Press; 1991. 82-105.
3. Rybak LP, Radhika R, Somani SM. Mechanism of Protection by Diethyldithiocarbamate against Cisplatin Ototoxicity: Antioxidant System. Fundamental and Apllied Toxicology. 1995;26:293-300.
4. Stadnicki SW, Gleischman RW, Schaaeppi U. Ototoxicity of Cisdichlorodiammine Platinum (II) (NSC-119875): Hearing loss and Other Toxic Effects in Rhesus Monkeys. Can Chemother Ver 1975;59:467-80.
5. Stengs CHM, Klis SFL, Huizing EH, Smoorenburg GF. Protective Effects of a Neurothophic ACTH (4-9) Analog on Cisplatin Ototoxicity in Relation to the Cisplatin Dose: An Electrocochleographic Study in Albino Guine Pigs. Hearing Res 1998;124:108-17.
6. Tognela S. Pharmacological Interventions To Reduce Platinum-induced Toxicity. Can Trat Ver 1990;17:139-42.
7. Towflight J, Strauss M, Lord S. Cisplatin Ototoxicity: Clinical Experience and Temporal Bone Hystopatology. Laryngoscope 1983;93:1554-9.
8. Wright CG, Schaeffer SD. Inner Ear Hystophatology in patients Treated With Cisplatin. Laringoscope 1982;92:1408-13.
9. Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol 2000;21(4):513-20.
10. Barron SE, Daihneault EA. Effect of Cisplatin on Hair Cell Morphology and Lateral Wall Na-K-ATP ase Activity. Hear Res 1987;26:131-7.
11. Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Dose-Dependent Effect of 8-Day Cisplatin Administration Upon the Morphology of the Albino Guinea Pig Cochlea. Hearing Res 2000;144:135-46.
12. Janning MH, Withworth CA, Rybak LP. Experimental Model of Cisplatin Ototoxicity in Chinchilas. Otolaryngol Head Neck Surg 1998;119(6):574-80.
13. Kohn SM, Fradis J, Zidan L, Podoshin E, Robinson & I Nir. Cisplatin Ototoxicity in Guinea Pigs with Special Reference to Toxic Effects in the Stria Vascularis. Laringoscope 1988;8;885-71.
14. Laurell G, Engström B. The Ototoxic Effect of Cisplatin in Guinea Pigs in Relation to Dosage. Hear Res 1989;38:27-34.
15. Stengs CHM, Klis SFL, Huizing EH, Smoorenburg GF. Cisplatin Ototoxicity. An Electrophysiological Dose-Effect Study in Albino Guinea Pigs. Hearin Res 1998;124:99-107.
16. Sockalingam R, Freeman S, Cherny TL, Sohmer H. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol 2000;21(4):521-7.
17. Stengs CH, Klis SF, Huizing EH, Smoorenburg GF. Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs. Hear Res 1998;124(1-2):99-107.
18. Saito T, Aran JM. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL J Otorhinolaryngol Relat Spec 1994;56(6):315-20.
19. Shaw NA. The Auditory Evoked Potential in the Rat - a Review. Prog Neurobiol 1988;31:19-45.
20. Stengs CH, Klis SF, Huizing EH, Smoorenburg GF. Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs. Hear Res 1998;124(1-2):108-17.
21. Sie KC, Norton SJ. Changes in otoacoustic emissions and auditory brain stem response after cis-platinum exposure in gerbils. Otolaryngol Head Neck Surg 1997;116(6 Pt 1):585-92.
22. Harel N, Kakigi A, Hirakawa H, Mount RJ, Harrison RV. The Effects of Anesthesia on Otoacoustic Emissions. Hearing Res 1997;110:25-33.
23. Cevette MJ, Drew D, Webb TM, Marion MS. Cisplatin ototoxicity increased DPOAE amplitudes and magnesium deficiency. Distortion product otoacoustic emissions. J Am Acad Audiol 2000;11(6):323-9.
24. Allen GC, Tiu C, Koike K, Ritchey AK, Kurs-Lasky M, Wax MK. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy. Otolaryngol Head Neck Surg 1998;118(5):584-8.
25. Ozturan O, Jerger J, Lew H, Lynch GR. Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions. Auris Nasus Larynx 1996;23:147-51.
26. Ress BD, Sridhar KS, Balkany TJ, Waxman GM, Stagner BB, Lonsbury-Martin BL. Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg 1999;121(6):693-701.
27. Ravi R, Somani SM, Rybak LP. Mechanism of Cisplatin Ototoxicity: Antioxidant System. Pharmacology & Toxicology. 1995;76:386-94.
28. McAlpine D, Johnstone BM. The Ototoxic Mechanism of Cisplatin. Hear Res 1990;47:191-203.
29. Miettinen S, Laurell G, Andersoson A, Johanson R, Laukikainen E. Blood Flow-Independent Accumulation of Cisplatin in the Guinea Pig Cochea. Acta Otolaryngol (Stockh) 1997;117:55-60.
30. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 2001;1174(1):27-34.
31. Watanabe KI, Hess A, Bloch W, Michel O. Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs. Anticancer Drugs 2000;11(5):401-6.
32. Evans P, Halliwell B. Free radicals and hearing. Cause consequence and criteria. Ann N Y Acad Sci 1999;28;884:19-40.
33. Huang T, Cheng AG, Stupak H, Liu W, Kim A, Staecker H, Lefebvre PP, Malgrange B, Kopke R, Moonen G, Van De Water TR. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 2000;18(2-3):259-70.
34. Maheswari KU, Ramachandran T, Rajaji D. Interaction of cisplatin with planar model membranes - dose dependent change in electrical characteristics. Biochim Biophys Acta 2000;15;1463(2):230-40.
35. Rybak LP, Whitworth MA, Somani S. Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity. The Laringoscope Nov 1999;109:1740-4.
36. Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Histological Effects of Co-administration of an ACTH(4-9) Analog ORG 2766 on Cisplatin Ototoxicity in the Albino Guinea Pig. Hearing Res 2000;144:157-67.
37. Laurell G, Engström B. The Combined Effect of Cisplatin and Furosemida on Hearing Function in Guinea Pigs. Hearing Res 1989;38:19-26.
38. Feghali JG, Liu W, Van De Water TR. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111(7):1147-50.
39. Gao WQ. Role of neurotrophins and lectins in prevention of ototoxicity. Ann N Y Acad Sci 1999;28:312-27.
40. Rybak LP, Somani S. Ototoxicity. Amelioration by protective agents. Ann N Y Acad Sci. 1999;28:143-51.
41. Cardinaal RM, de Groot JC, Huizing EH, Veldman JE, Smoorenburg GF. Histological effects of co-administration of an ACTH((4-9)) analogue ORG 2766 on cisplatin ototoxicity in the albino guinea pig. Hear Res 2000;144(1-2):157-67.
42. Kamimura T, Whitworth CA, Rybak LP. Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat. Hear Res 1999;131(1-2):117-27.
43. Rybak LP, Husain K, Whitworth C, Somani SM. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system. Toxicol Sci 1999;47(2):195-202.
44. Heijmen PS, Klis SF, De Groot JC, Smoorenburg GF. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulating hormone. Hear Res 1999;128(1-2):27-39.
45. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F. Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 2000;28(2):73-80.
46. Fukaya H, Kanno H. Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats. Nippon Jibiinkoka Gakkai Kaiho 1999;102(7):907-17.
47. Jordan JA, Schwade ND, Truelson JM. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum. Laryngoscope 1999;109(8):1259-62.
48. Canedo DJM. Resistência a Ação Ototóxica de Antibióticos Aminoglicosídeos. Tese de Mestrado. Faculdade de Medicina de Ribeirão Preto - USP. 1999.
49. Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Cisplatin-Induced Ototoxicity: Morphological Evidence of Spontaneous Outer Harir Cll Recovery in Albino Guinea Pigs? Hearing Res 2000;144147-156.
50. Smoorenburg GF, De Groot JC, Hamers FP, Klis SF. Protection and spontaneous recovery from cisplatin-induced hearing loss. Ann N Y Acad Sci 1999;28;884:192-210.
51. Klis SF, O'Leary SJ, Hamers FP, De Groot JC, Smoorenburg GF. Reversible cisplatin ototoxicity in the albino guinea pig. Neuroreport 2000;11(3):623-6.
52. Ekborn A, Laurell G, Anderson A, Wallim I, Eksborg S, Ehrsson H. Cisplatin-Induced Hearing Loss: influence of the Mode of Drug Administration in the Guinea Pig. Hearing Res 2000;140:38-34.
53. Taudy M, Syka J, Popelár J, Úehlová L, Carboplatin and Cisplatin Ototoxicity in Guinea Pigs. Audiology 1992;31:293-299.
54. Hatzopoulos S, Di Stefano M, Albertin A, Martini A. Evaluation of cisplatin ototoxicity in a rat animal model. Ann N Y Acad Sci 1999;28:211-25.
55. Saito T, Manabe Y, Honda N, Yamada T, Yamamoto T, Saito H. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs. Scanning Microsc 1995;9(1):271-80; discussion 280-1.
56. Bridi R, Crossetti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res 2001;15(5):449-51.
57. Sasaki K, Hatta S, Wada K, Ueda N, Yoshimura T, Endo T, Sakata M, Tanaka T, Haga M. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci 2002;22;70(14):1657-67.
58. Carini M, Aldini G, Rossoni G, Morazzoni P, Facino RM. Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increases the plasma antioxidant capacity in the rat. Planta Med 2001;67(4):326-30.
59. Siddique MS, Eddeb F, Mantle D, Mendelow AD. Extracts of Ginkgo biloba and Panax ginseng protect brain proteins from free radical induced oxidative damage in vitro. Acta Neurochir Suppl 2000;76:87-90.
60. Louajri A, Harraga S, Godot V, Toubin G, Kantelip JP, Magnin P. The effect of ginkgo biloba extract on free radical production in hypoxic rats. Biol Pharm Bull 2001;24(6):710-2.
61. Gohil K, Moy RK, Farzin S, Maguire JJ, Packer L. mRNA expression profile of a human cancer cell line in response to Ginkgo biloba extract: induction of antioxidant response and the Golgi system. Free Radic Res 2000;33(6):831-49.
62. Fosslien E. Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 2001;31(1):25-67. Review.